Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration

Published:2023-12 Issue: Volume:256 Page:20-26
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Awh Katherine C.^ORCID,Mahmoudzadeh Raziyeh^ORCID,Salabati Mirataollah^ORCID,Mansour Hana A.^ORCID,Bechay Joseph,Magagna John,Regillo Carl D.,Ho Allen C.^ORCID,Garg Sunir J.,Hsu Jason^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference21 articles.

1. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results;Martin;Ophthalmology,2012

2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

3. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

4. Canadian treat-and-extend analysis trial with ranibizumab in patients with neovascular age-related macular disease: one-year results of the Randomized Canadian Treat-and-Extend Analysis Trial with Ranibizumab Study;Kertes;Ophthalmology,2019

5. Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months;Nguyen;Ophthalmol Retina,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neovaskuläre altersabhängige Makuladegeneration: Aussetzung von Anti-VEGF-Injektionen kann in bestimmten Fällen sinnvoll sein;Klinische Monatsblätter für Augenheilkunde;2024-05